These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24374838)
21. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer. Cai Z; Chen W; Zhang J; Li H Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923 [TBL] [Abstract][Full Text] [Related]
22. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Gao S; Ye H; Gerrin S; Wang H; Sharma A; Chen S; Patnaik A; Sowalsky AG; Voznesensky O; Han W; Yu Z; Mostaghel EA; Nelson PS; Taplin ME; Balk SP; Cai C Clin Cancer Res; 2016 Jul; 22(14):3672-82. PubMed ID: 26936914 [TBL] [Abstract][Full Text] [Related]
23. Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor. Patki M; Huang Y; Ratnam M Biochem Biophys Res Commun; 2016 Jul; 476(2):69-74. PubMed ID: 27179779 [TBL] [Abstract][Full Text] [Related]
24. Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma. Adler D; Offermann A; Halbach R; Vogel W; Braun M; Kristiansen G; Bootz F; Wenzel J; Mikut R; Lengerke C; Reischl M; Schröck A; Perner S Am J Pathol; 2015 Apr; 185(4):1114-22. PubMed ID: 25791637 [TBL] [Abstract][Full Text] [Related]
25. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300 [TBL] [Abstract][Full Text] [Related]
26. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. Pallasaho S; Gondane A; Kuivalainen A; Girmay S; Moestue S; Loda M; Itkonen HM J Cancer Res Clin Oncol; 2023 Jul; 149(8):5255-5263. PubMed ID: 36401094 [TBL] [Abstract][Full Text] [Related]
27. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
28. Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis. Xiao L; Wang Y; Xu K; Hu H; Xu Z; Wu D; Wang Z; You W; Ng CF; Yu S; Chan FL Cancer Res; 2018 May; 78(9):2205-2218. PubMed ID: 29438990 [TBL] [Abstract][Full Text] [Related]
29. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Savoy RM; Chen L; Siddiqui S; Melgoza FU; Durbin-Johnson B; Drake C; Jathal MK; Bose S; Steele TM; Mooso BA; D'Abronzo LS; Fry WH; Carraway KL; Mudryj M; Ghosh PM Endocr Relat Cancer; 2015 Jun; 22(3):369-86. PubMed ID: 25759396 [TBL] [Abstract][Full Text] [Related]
30. Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC). Li Y; Shi H; Zhao Z; Xu M BMC Urol; 2022 Oct; 22(1):162. PubMed ID: 36258196 [TBL] [Abstract][Full Text] [Related]
31. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis. Hagberg Thulin M; Nilsson ME; Thulin P; Céraline J; Ohlsson C; Damber JE; Welén K Mol Cell Endocrinol; 2016 Feb; 422():182-191. PubMed ID: 26586211 [TBL] [Abstract][Full Text] [Related]
32. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803 [TBL] [Abstract][Full Text] [Related]
33. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cato L; de Tribolet-Hardy J; Lee I; Rottenberg JT; Coleman I; Melchers D; Houtman R; Xiao T; Li W; Uo T; Sun S; Kuznik NC; Göppert B; Ozgun F; van Royen ME; Houtsmuller AB; Vadhi R; Rao PK; Li L; Balk SP; Den RB; Trock BJ; Karnes RJ; Jenkins RB; Klein EA; Davicioni E; Gruhl FJ; Long HW; Liu XS; Cato ACB; Lack NA; Nelson PS; Plymate SR; Groner AC; Brown M Cancer Cell; 2019 Mar; 35(3):401-413.e6. PubMed ID: 30773341 [TBL] [Abstract][Full Text] [Related]
34. Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance. Li S; Hu MG; Sun Y; Yoshioka N; Ibaragi S; Sheng J; Sun G; Kishimoto K; Hu GF Mol Cancer Res; 2013 Oct; 11(10):1203-14. PubMed ID: 23851444 [TBL] [Abstract][Full Text] [Related]
35. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT. Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682 [TBL] [Abstract][Full Text] [Related]
36. Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer. Mostaghel EA; Zhang A; Hernandez S; Marck BT; Zhang X; Tamae D; Biehl HE; Tretiakova M; Bartlett J; Burns J; Dumpit R; Ang L; Matsumoto AM; Penning TM; Balk SP; Morrissey C; Corey E; True LD; Nelson PS Clin Cancer Res; 2019 Jan; 25(1):426-439. PubMed ID: 30181386 [TBL] [Abstract][Full Text] [Related]
37. Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. Benelli R; Barboro P; Costa D; Astigiano S; Barbieri O; Capaia M; Poggi A; Ferrari N Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816863 [TBL] [Abstract][Full Text] [Related]
38. Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer. Ferrari N; Granata I; Capaia M; Piccirillo M; Guarracino MR; Venè R; Brizzolara A; Petretto A; Inglese E; Morini M; Astigiano S; Amaro AA; Boccardo F; Balbi C; Barboro P Cell Commun Signal; 2017 Dec; 15(1):51. PubMed ID: 29216878 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progression. Gowda PS; Deng JD; Mishra S; Bandyopadhyay A; Liang S; Lin S; Mahalingam D; Sun LZ Mol Cancer Res; 2013 Nov; 11(11):1448-61. PubMed ID: 23989930 [TBL] [Abstract][Full Text] [Related]
40. Improved therapeutic targeting of the androgen receptor: rational drug design improves survival in castration-resistant prostate cancer. Lim AC; Attard G Curr Drug Targets; 2013 Apr; 14(4):408-19. PubMed ID: 23565754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]